$GRCE
Grace Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GRCE up today? It is at $2.20 (+2.80%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GRCE spikes, and full due diligence on GRCE — key stats, earnings, dilution and insider activity. Free.
Get free $GRCE alerts the moment volume spikes
Our scanner flagged $GRCE 5 times in the last 30 days. Create a free account to track $GRCE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.20
- Change today
- +2.80%
- Previous close
- $2.14
- 52-week range
- $1.79 – $5.18
- Market cap
- $46M
- Shares outstanding
- 21.0M SEC · as of 2026-08-11 · 12d
- Institutional own.
- 20.32%
- Total held
- 29.2%
- Tradeable float
- 14.9M 71% of shares · after 9% insiders + 20% institutions
- Short interest
- 1.6M ▼ -3% vs prior · as of 2026-07-31
- Short % of float
- 10.7%
- Days to cover
- 5.7d
- Avg daily volume
- 299K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 1.3x
- 15m
- 1.1x
- 1h
- 0.6x
- 1D
- --
Get free GRCE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $GRCE up today?
Here is the latest on GRCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying1 open-market buy1 buys, 0 sells last 3 months (1/0 over 12 months)Show 1 recent transactionMinimize 1 recent transaction
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Opaleye Management Inc. Beneficial Owner (10%) | Bought (open market) | +12K 0.06% of company | added 0.4% | 2.76M | $24K at $2.09 | Aug 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $GRCE. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$GRCE Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$GRCE Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to GRCE
Comparable names in pharmaceutical preparations, closest in size first.
GRCE stock FAQ
Why is $GRCE up today?
Here is the latest on GRCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GRCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the GRCE stock price today?
GRCE last traded at $2.20, up 2.80% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live GRCE alerts?
The GRCE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GRCE 5 times in the last 30 days.
What exchange is GRCE on?
GRCE (Grace Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $46M in the PHARMACEUTICAL PREPARATIONS sector.
Is GRCE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GRCE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.